A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers

Completed · Phase 1

Conditions studied: Smoking, Tobacco Use Disorder

In brief

A randomized, double-blind, active-controlled, crossover, pilot study to evaluate the safety and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily reducing the desire to smoke

Key facts

Study ID

NCT01262170

Run by

Rock Creek Pharmaceuticals, Inc.

People needed

109

Starts

2010-04-01

Expected to finish

2010-04-01

Last updated by the study team

2015-10-30

Who can join

Age: 23 and older, up to 72. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adult smokers
• Smoking for at least 5 years
• Smoking at least one (1) pack of cigarettes a day

You may not qualify if…

• Allergy to lozenge components

Where it is running

• Comfort Inn — Martinsburg, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.